| Structure |
Chemical Name |
CAS |
MF |
 |
Aprepitant iMpurity 41 |
|
|
|
|
(E)-3'-(2-(1-(3,4-dimethylphenyl) |
|
|
 |
Tenofovir |
34956-22-4 |
C14H23O6PS |
|
|
Afatinib Impurity YHQ |
|
|
![Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide](/CAS/20210305/GIF/2004659-83-8.gif) |
Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide |
2004659-83-8 |
C20H19N5O3 |
 |
Cabozantinib Impurity 49 |
190728-26-8 |
C17H14N2O5 |
|
|
Landiolol impurity S |
|
|
 |
Mupirocin Calcium EP Impurity G |
|
C26H44CaO9 |
 |
Atorvastatin Impurity 40 |
1116118-82-1 |
C50H64FN3O8 |
|
|
Hyoscine Butylbromide EP Impurity F |
|
|
|
|
Tocopherol EP Impurity D |
|
|
|
|
Org246653-1(RRT0.35) |
|
|
![1H-Isoindole-1,3(2H)-dione, 2-[(2S)-2,3-dihydroxypropyl]-](/CAS/20200401/GIF/119835-88-0.gif) |
1H-Isoindole-1,3(2H)-dione, 2-[(2S)-2,3-dihydroxypropyl]- |
119835-88-0 |
C11H11NO4 |
 |
Brexpiprazole Impurity 76 |
433303-94-7 |
C12H14N2S |
 |
Phenacetin Impurity 3 |
24176-84-9 |
C14H13ClN2O2 |
 |
2-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-1-ol |
109632-11-3 |
C15H25NO3 |
|
|
Pabuxilibu impurities |
3079368-27-4 |
|
|
|
ERYTHROMYCIN IMPURITY G |
|
|
 |
Methyl-5-chlorothiophene-2-carboxylate |
35475-03-7 |
C6H5ClO2S |
![2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide](/CAS/20180601/GIF/1276524-56-1.gif) |
2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide |
1276524-56-1 |
C17H10D4F3N3O3S |
 |
1,1-diphenylpropan-1-ol |
5180-33-6 |
C15H16O |
 |
(R)-De(trifluoromethyl) Fluoxetine Hydrochloride |
1212215-97-8 |
C16H20ClNO |
![(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one](/CAS/20180601/GIF/96847-52-8.gif) |
(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
96847-52-8 |
C11H10O2 |
![(1R,1'R,2S,2'S)-2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-Isoquinolinium Benzenesulfonate](/CAS/20210111/GIF/96946-46-2.gif) |
(1R,1'R,2S,2'S)-2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-Isoquinolinium Benzenesulfonate |
96946-46-2 |
C59H77N2O15S+ |
 |
(2R,3R,4R,5R)-2-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-3-yl acetate |
|
C10H14N4O6 |
![12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate](/CAS/20180703/GIF/176515-52-9.gif) |
12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate |
176515-52-9 |
C32H38N4O4 |
 |
4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
|
C17H24ClN3O2 |
|
|
Ceftazidime Impurity D |
|
|
|
|
Ceftazidime Sulfoxide Impurity |
|
|
|
|
Tofacitinib Impurity Y |
|
|
 |
5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol |
|
C7H10ClN3OS |
|
|
Labetalol EP impurity G |
|
|
 |
2-(2-NITROPHENYL)ETHANAMINE |
33100-15-1 |
C8H10N2O2 |
 |
CLOZAPINE-D3 |
1215691-72-7 |
C18H19ClN4 |
|
|
Bumetanide iMpurity F |
|
|
![IODIXANOL RELATED COMPOUND D (50 MG) (5-[ACETYL(2-HYDROXY-3-METHYLPROPYL)AMINO]-N,N'-BIS(2,3-DIHYDROXYPROPYL)2,4,6-TRIIODO-1,3-BENZE-NEDICARBOXAMIDE)](/CAS/GIF/89797-00-2.gif) |
IODIXANOL RELATED COMPOUND D (50 MG) (5-[ACETYL(2-HYDROXY-3-METHYLPROPYL)AMINO]-N,N'-BIS(2,3-DIHYDROXYPROPYL)2,4,6-TRIIODO-1,3-BENZE-NEDICARBOXAMIDE) |
89797-00-2 |
C20H28I3N3O9 |
 |
NIMODIPINE RELATED COMPOUND B (50 MG) (BIS(2-METHOXYETHYL) 2,6-DIMETHYL-4-(3-NITROPHE-NYL)-1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLATE) (AS) |
70172-96-2 |
C21H26N2O8 |
|
|
Amylmetacresol EP impurity E |
|
|
 |
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanamide |
2232201-72-6 |
C11H18N2O3 |
 |
methyl 1-hydroxy-2-oxoindoline-6-carboxylate |
1895918-24-7 |
C10H9NO4 |
|
|
Dapagliflozin Impurity (MW: 437Da) |
|
|
|
|
Cetirizine Impurity BHA |
|
|
|
|
Macitentandesbromopyrimidine Impurity |
|
|
|
|
Cilastatin EP Impurity H |
|
|
 |
Febuxostat Impurity 130 |
1643131-93-4 |
C20H25NO5S |
|
|
(2-Chlorophenyl)diphenylmethanol |
|
|
 |
Nilotinib Impurity 27 |
1807606-80-9 |
C28H22F3N7O2 |
|
|
Vonoprazan Impurity 53 |
|
|
|
|
Vonoprazan Impurity 61 |
|
|
|
|
Emtricitabine Ring-opening Impurity |
|
|
|
|
Tafluprost Impurity 1 (Tafluprost (1S,2S,3S,5R)-Isomer) |
|
|
 |
Escitalopram Butyryl Impurity |
1803244-58-7 |
C25H33FN2O2 |
|
|
Oseltamivir isomer impurity |
|
|
 |
Ethyl 4-bromo-3-hydroxybutyrate |
32224-01-4 |
C6H11BrO3 |
 |
1-METHYL-2-PHENOXYETHYLAMINE |
35205-54-0 |
C9H13NO |
|
|
SULPIRIDE IMPURITY B |
|
|
![2-[(5-CARBOXY-4-METHOXY-3-METHYLPYRID-2-YL)-METHYLSULFO]-5-METHOXYBENZIMIDAZOLE](/CAS/GIF/120003-72-7.gif) |
2-[(5-CARBOXY-4-METHOXY-3-METHYLPYRID-2-YL)-METHYLSULFO]-5-METHOXYBENZIMIDAZOLE |
120003-72-7 |
C17H17N3O5S |
|
|
Gadobutrol Impurity 3 |
2227984-48-5 |
|
|
|
Empagliflozin Impurity 84 |
|
|
|
|
Iohexol Impurity O |
|
|
|
|
Avibactam sodium Impurity CES |
|
|
 |
(2,5-dichlorophenyl)(4-ethoxyphenyl)methanone |
1097076-93-1 |
C15H12Cl2O2 |
 |
Lenvatinib impurity LFZZ-10 |
|
C11H8Cl2N2O2 |
|
|
(2S,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate |
|
|
|
|
Febuxostat Impurity 98 |
|
|
|
|
(2-(methyl((vinyloxy)carbonyl)amino)pyridin-3-yl)methyl 2-(methylamino)acetate hydrochloride |
|
|
 |
1-(4-bromo-3,5-dimethoxyphenyl)ethanone |
1333472-28-8 |
C10H11BrO3 |
|
|
Ticagrelor Impurity 117 |
|
|
|
|
Ticagrelor Impurity 136 |
|
|
 |
Phenol, 2-(diphenylmethyl)-5-methyl- |
411239-19-5 |
C20H18O |
 |
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-(formylamino)-, ethyl ester, (3R,4R,5S)- |
2148317-96-6 |
C17H28N2O5 |
![Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(5-chloro-2-ethoxyphenyl)-5-methyl-7-propyl-](/CAS/20200611/GIF/2245167-80-8.gif) |
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(5-chloro-2-ethoxyphenyl)-5-methyl-7-propyl- |
2245167-80-8 |
C17H19ClN4O2 |
 |
Posaconazole impurity 18 |
1819334-66-1 |
C44H49F2N8O4+ |
 |
(4S,6R)-6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxane-4-carboxylic acid |
2095786-11-9 |
C13H22O6 |
 |
Crisaborole intermediate |
2354382-27-5 |
C14H8BCl2NO3 |
|
|
Ropivacaine Impurity 48 |
|
|
![2,4-Heptadienoic acid, 7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-, (2Z,4E)-](/CAS/20210111/GIF/1148131-09-2.gif) |
2,4-Heptadienoic acid, 7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-, (2Z,4E)- |
1148131-09-2 |
C33H31FN2O3 |
 |
2(3H)-Furanone, dihydro-4-(1-methylethyl)-, (4S)- |
53657-15-1 |
C7H12O2 |
 |
Crisaborole Impurity 9 HCl |
1187187-01-4 |
C14H15BClNO3 |
![2H-Indol-2-one, 3-[[3,5-dimethyl-4-(1-pyrrolidinylcarbonyl)-1H-pyrrol-2-yl]methylene]-5-fluoro-1,3-dihydro-](/CAS/20210111/GIF/2135339-43-2.gif) |
2H-Indol-2-one, 3-[[3,5-dimethyl-4-(1-pyrrolidinylcarbonyl)-1H-pyrrol-2-yl]methylene]-5-fluoro-1,3-dihydro- |
2135339-43-2 |
C20H20FN3O2 |
|
|
Nicergoline Impurity 02 |
|
|
|
|
Bromhexine ImpurityABCDEFGHJKL |
|
|
![1-Butanone, 1-(4-fluorophenyl)-4-[(6bR,10aR)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-](/CAS/20200611/GIF/1576240-16-8.gif) |
1-Butanone, 1-(4-fluorophenyl)-4-[(6bR,10aR)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]- |
1576240-16-8 |
C24H28FN3O |
|
|
impurity 37 |
|
|
![3-(7,8-dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)-N-(((S)-3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylpropan-1-amine oxide](/CAS/20210305/GIF/2511244-97-4.gif) |
3-(7,8-dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)-N-(((S)-3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylpropan-1-amine oxide |
2511244-97-4 |
C27H36N2O6 |
 |
2,4,6,3',5'-pentamethoxybiphenyl |
84212-55-5 |
C17H20O5 |
|
|
Labetalol EP Impurity I |
|
|
|
|
(Asp4)-Carbetocin (Impurity G) |
|
|
![Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-chloro-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl-](/CAS/20210305/GIF/2443747-63-3.gif) |
Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-chloro-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl- |
2443747-63-3 |
C19H20BrClN6O4S |
 |
methyl 3-oxo1,2-benzisothiazole-2(3H)-acetate 1,1-dioxide |
6639-62-9 |
C10H9NO5S |
![(6R-cis)-3-(hydroxymethyl)-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](/CAS/GIF/54333-94-7.gif) |
(6R-cis)-3-(hydroxymethyl)-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
54333-94-7 |
C15H16N2O6S2 |
 |
5-acetyl-1,3-phenylene bis(dimethylcarbamate) |
81732-48-1 |
C14H18N2O5 |
|
|
Oseltamivir Impurity L |
|
|
 |
1,4-Naphthalenediol, 2-methyl-, 4-acetate |
110327-29-2 |
C13H12O3 |
|
|
Oseltamivir Impurity 105 |
|
|
|
|
Oseltamivir Impurity 77 |
|
|
|
|
Imidapril Impurity 2 |
|
|
 |
Betamethasone EP Impurity G |
85700-75-0 |
C22H30O5 |
|
|
Crisaborole Impurity ABCDEFGHJKL |
|
|
![3-Azetidinecarboxylic acid, 1-[(4-acetyl-2-ethylphenyl)methyl]-](/CAS/20210305/GIF/2474774-17-7.gif) |
3-Azetidinecarboxylic acid, 1-[(4-acetyl-2-ethylphenyl)methyl]- |
2474774-17-7 |
C15H19NO3 |